Skip to main content
. 2023 Oct 15;13(5):152–161.

Table 1.

Baseline characteristics

Characteristics GT n=30 ST n=30 p value
Age 5.5 (4-10.2) 5 (4-9.2) 0.70
Gender 0.59
    Male 18 (60%) 21 (70%)
    Female 12 (40%) 9 (30%)
Primary diagnosis
    Hematological malignancies
        ALL 10 (33.3%) 14 (46.7%) 0.54
        AML 6 (20%) 7 (23.3%)
        ALL relapse 3 (10%) 1 (3.3%)
        AML relapse 1 (3.3%) 1 (3.3%)
        Lymphomas 3 (10%) 5 (16.7%)
    Solid tumors
        Retinoblastoma 1 (3.3%) 1 (3.3%)
        Ewing’s sarcoma 4 (13.3%) 1 (3.3%)
        Others 2 (6.7%) 0
Focus of infection
    Respiratory 10 (33%) 10 (33%) 0.21
    GI 17 (57%) 11 (37%)
    Both 0 1 (3%)
    No focus 3 (10%) 8 (27%)
CXR abnormality at admission 2 (7.1%) 4 (14.3%) 0.67
Total febrile period before admission (days) 3 (1-5.2) 3 (1-7) 0.32
Antibiotic received before admission
    No antibiotics 13 (43.3%) 14 (46.7%) 0.90
    First line antibiotics 4 (13.3%) 4 (13.3%)
    Second line antibiotics 12 (40%) 10 (30.3%)
    Empirical Antifungals 1 (3.3%) 2 (6.7%)

Categorical variables were compared using Chi-square test and continuous variables using Mann-Whitney U test.